Journal Home
Search for

Volume 31, Issue 5, Pages 747-757 (May 2010)


View previous. 4 of 21 View next.

Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease

Oliver WirthsaCorresponding Author Informationemail address, Henning Breyhana, Andrea Marcelloa, Marie-Caroline Cotela, Wolfgang Brückb, Thomas A. Bayera

Received 31 January 2008; received in revised form 20 June 2008; accepted 20 June 2008. published online 28 July 2008.

Abstract 

Inflammatory processes are considered to play an important role in the progression of neurodegenerative changes in Alzheimer's disease (AD). In the present study, we performed a systematic expression analysis of various inflammatory and oxidative stress markers in pre-symptomatic and diseased APP/PS1KI mice. This mouse model has been previously shown to harbor severe pathological alterations, including behavioral deficits, axonal degeneration and hippocampal neuron loss starting at the age of 6 months. While the expression levels of most markers remained unchanged in 2-month-old APP/PS1KI mice, at the age of 6 months different astro- and microglia markers including GFAP, Cathepsin D, members of the Toll-like receptor (Tlr) family, TGFβ-1 and osteopontin were up-regulated. In addition, oxidative stress markers, including the metallothioneins, were also significantly elevated at that time point. As expected, both brain and spinal cord were affected, the latter showing early activation of GFAP-positive astrocytes and Iba1-positive microglia in white matter fiber tracts, which might contribute to the previously reported axonal defects in this mouse model. These data add further evidence to the assumption that inflammatory processes are tightly associated with axonal degeneration and neuron loss, as is evident in the APP/PS1KI mouse model.

a Division of Molecular Psychiatry and Alzheimer Ph.D. Graduate School, Department of Psychiatry, University of Goettingen, von-Siebold-Str. 5, 37075 Goettingen, Germany

b University of Goettingen, Department of Neuropathology, Robert-Koch-Str. 40, 37075 Göttingen, Germany

Corresponding Author InformationCorresponding author at: Department of Psychiatry, Division of Molecular Psychiatry, University of Göttingen, Von-Siebold-Strasse 5, 37075 Göttingen, Germany. Tel.: +49 551 39 10290; fax: +49 551 39 10291.

PII: S0197-4580(08)00218-2

doi:10.1016/j.neurobiolaging.2008.06.011


View previous. 4 of 21 View next.